Treanda
(Bendamustine HCL)
| Manufacturer: Cephalon |
| General Information: Treanda is typically utilized for the treatment of patients with chronic lymphocytic leukemia and previously treated, indolent B-cell non-Hodgkin's lymphoma. For indications, dosing and other information, please refer to the maufacture package insert. |
| |
|
Product |
Size |
NDC Number |
PI |
MSDS |
| Treanda |
25mg/8mL |
63459-0390-08 |
PI |
MSDS |
| |
100mg/20mL |
63459-0391-20 |
PI |
MSDS |
|
| |
| |
| Clinical
Data: For any questions
or for further information
related to Treanda, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |